Andrew R Moore Selected Research

YF 476

1/2020	Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
1/2017	Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
1/2016	Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.
1/2013	Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew R Moore Research Topics

Disease

8	Pain (Aches) 01/2014 - 06/2002
5	Atrophic Gastritis 01/2021 - 01/2013
4	Acute Pain 01/2014 - 06/2004
3	Adenocarcinoma 01/2018 - 01/2016
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 01/2016
2	Achlorhydria (Hypochlorhydria) 01/2017 - 01/2013
2	Low Back Pain (Lumbago) 12/2010 - 06/2010
2	Headache (Headaches) 04/2006 - 06/2002
1	COVID-19 12/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Infections 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Barrett Esophagus (Barrett's Esophagus) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 11/2017
1	Neoplasms (Cancer) 01/2016
1	Wounds and Injuries (Trauma) 07/2015
1	Hemorrhage 05/2013
1	Ankylosing Spondylitis 07/2011
1	Cancer Pain 12/2004
1	Musculoskeletal Pain 12/2004
1	Ulcer 10/2004
1	Osteoarthritis 10/2004
1	Rheumatoid Arthritis 10/2004
1	Arthritis (Polyarthritis) 10/2004
1	Postoperative Pain 08/2002
1	Migraine Disorders (Migraine) 06/2002

Drug/Important Bio-Agent (IBA)

7	Analgesics (Analgesic Drugs)IBA 07/2012 - 06/2002
5	GastrinsIBA 01/2021 - 01/2013
4	YF 476IBA 01/2020 - 01/2013
3	Ibuprofen (Motrin)FDA LinkGeneric 01/2014 - 04/2006
3	EtoricoxibIBA 07/2011 - 12/2010
2	Proton Pump InhibitorsIBA 01/2021 - 11/2017
2	Cholecystokinin B ReceptorIBA 01/2017 - 01/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2013 - 04/2006
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2013 - 10/2004
2	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2011 - 04/2006
2	Sumatriptan (Imigran)FDA LinkGeneric 04/2006 - 06/2002
1	InterferonsIBA 12/2021
1	SmokeIBA 01/2021
1	AntralIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 11/2017
1	Chromogranin AIBA 01/2017
1	Hormones (Hormone)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	SaltsIBA 01/2014
1	AcidsIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Naproxen (Naprosyn)FDA LinkGeneric 07/2011
1	rofecoxib (Vioxx)FDA Link 04/2006
1	Pharmaceutical PreparationsIBA 04/2006
1	Opioid Analgesics (Opioids)IBA 12/2004
1	valdecoxib (Bextra)FDA Link 10/2004
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2004
1	Morphine (MS Contin)FDA LinkGeneric 08/2002
1	naratriptan FDA LinkGeneric 06/2002
1	Pain-FreeIBA 06/2002

Therapy/Procedure

1	Analgesia 01/2014
1	Therapeutics 05/2010